Normal view

There are new articles available, click to refresh the page.
Yesterday — 15 December 2025Cannabis

Trump confirms marijuana rescheduling interest but timeline uncertain

15 December 2025 at 19:11

President Donald Trump confirmed Monday the White House is “very strongly” considering loosening federal restrictions on cannabis, a move that would boost the $32 billion legal industry’s margins and portend future, more ambitious reforms.

However, Trump declined to offer a precise timeline, meaning last week’s prediction that an executive order moving marijuana to Schedule 3 of the Controlled Substances Act could come as soon as Monday has already been proven wrong.

ADVERTISEMENT

In response to a reporter’s questions during an unrelated event in the White House on Monday, Trump confirmed his interest in the issue.

“We are considering it,” he said.

“Because, uh, a lot of people want to see it — the reclassification — because it leads to tremendous amounts of research that

The post Trump confirms marijuana rescheduling interest but timeline uncertain appeared first on GrowCola.com.

Kentucky launches medical marijuana sales as first dispensary opens

15 December 2025 at 16:41

Kentucky’s first medical marijuana dispensary opened on Saturday, nearly one year after the program launched.

However, supply at The Post Dispensary in Beaver Dam was limited and expected to run out on the same day as the state’s slow rollout of medical cannabis continues, according to the Lexington Herald Leader.

ADVERTISEMENT

Four cultivators have also been approved to grow medical marijuana in Kentucky, and nearly 24,000 residents have been issued MMJ cards, according to Gov. Andy Beshear.

Beshear signed medical marijuana legalization into law in 2023. The program launched on Jan. 1, 2025 – but with no medical cannabis available.

Another 48 licensed MMJ dispensaries in the process of opening. One additional dispensary, has been approved to operate, the newspaper reported.

ADVERTISEMENT

The post Kentucky launches medical marijuana sales as first dispensary opens appeared first on GrowCola.com.

Only Six Percent Of Marijuana Consumers Approve Of Trump’s Reform Actions, But Most Would Shift Opinion If He Reschedules, Poll Finds

15 December 2025 at 16:16

Only six percent of marijuana consumers approve of the Trump administration’s actions on cannabis policy to date, according to a new survey that comes as rumors churn that the president intends to direct federal cannabis rescheduling.

The latest iteration of a quarterly presidential approval tracking poll from NuggMD and Marijuana Moment also found that 51 percent of respondents would be more likely to embrace the current administration if it rescheduled or legalized marijuana.

While some are bullish on recent news that President Donald Trump may move forward with plans to reclassify cannabis as a Schedule III, rather than Schedule I, drug under the Controlled Substances Act, marijuana users’ support for the president’s marijuana “actions” took a dip over the last quarter.

Just 1.6 percent of respondents said they “strongly approve” of the actions, 4.5 percent said they approve, a plurality of 38.4 percent were neutral, 26.1 percent disapproved and 29.5 percent strongly disapproved.

“Do you approve or disapprove of the presidential administration’s actions on cannabis?” n: % Strongly approve 7 1.6% Approve 20 4.5% No opinion/Neutral 172 38.4% Disapprove 117 26.1% Strongly disapprove

The post Only Six Percent Of Marijuana Consumers Approve Of Trump’s Reform Actions, But Most Would Shift Opinion If He Reschedules, Poll Finds appeared first on GrowCola.com.

Trump Says He’s ‘Very Strongly’ Considering Rescheduling Marijuana As Rumors Swell About Imminent Reform

15 December 2025 at 15:58

President Donald Trump on Monday confirmed that the administration is “very strongly” considering a proposal to federally reschedule marijuana because it would boost research into the effects of cannabis.

“We are” weighing rescheduling, Trump told reporters after being asked about the issue at an unrelated signing ceremony. He added that “a lot of people want to see it—the reclassification—because it leads to tremendous amounts of research that can’t be done unless you reclassify.”

“So we are looking at that very strongly,” he said.

The question to the president came amid heightened speculation about a possibly imminent rescheduling decision. CNBC reported it could come as early as Monday, but so far that has not materialized.

.@POTUS on marijuana rescheduling: “A lot of people want to see it — the reclassification — because it leads to tremendous amounts of research that can’t be done unless you reclassify, so we are looking at that very strongly.” pic.twitter.com/Ugych6rLCQ

— Rapid Response 47 (@RapidResponse47) December 15, 2025

It remains to be seen whether Trump will fulfill his campaign promise to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA), which would not legalize the plant but would

The post Trump Says He’s ‘Very Strongly’ Considering Rescheduling Marijuana As Rumors Swell About Imminent Reform appeared first on GrowCola.com.

The best kush strains to prep for the longest night

15 December 2025 at 11:41

The winter solstice marks the longest night of the year. Across cultures, this moment has always symbolized rest, reflection, and a gradual return of light. It's a natural pause in the calendar that invites people to reset before heading into a new season.

For many cannabis consumers, this night has also become an ideal moment to create intentional rituals, whether that is journaling, connecting with friends, or simply getting comfortable at home. 

Kush strains fit that mood well. Known for their body-centered and calming qualities, they often support the quiet atmosphere that many people seek during the solstice.

We highlighted the best kush cultivars that pair naturally with how you might want to spend the longest night of the year — whether you are seeking introspection, cozy creativity, warm connection, or full winter hibernation.

Why kush strains work for the winter solstice

Kush genetics trace back to the Hindu Kush mountain region, renowned for its hardy landrace strains that have adapted to cold nights and rugged conditions. These plants typically express dense buds, earthy or pine-leaning aromas, and effects that users often describe as grounding and relaxing.

Those qualities match the themes of the solstice. When the intention is to slow down or reflect, many users report that kush strains create a calm physical baseline and a steady mental space.

Kush strains for your winter solstice ritual

Here are eight kush strains that align with different solstice intentions. Each includes a quick look at genetics, sensory notes, and user-reported effects so you can choose the right flower for your festive night.

OG Kush

Lineage: Refined from early '90s kush genetics by Josh D

Known for its blend of citrus, pine, and gas, OG Kush remains one of the most influential strains in modern cannabis. Users often describe a balanced experience that feels both relaxing and social, which makes it a good choice for solstice nights spent with friends. If your evening involves conversation, cooking together, or reconnecting, OG Kush tends to support that warm energy.

Hindu Kush

Lineage: Pure indica landrace

Hindu Kush carries sweet, woody, and hashy notes. Users often report a steady, relaxing body feel and a calm mental state, making this a natural choice for meditation, intention setting, or quiet personal rituals. It matches well with a solstice focused on stillness and reflection.

Purple Kush

Lineage: Hindu Kush crossed with Purple Afghani

Purple Kush often shows rich coloration and a sweet, earthy aroma. Users describe deeply relaxing body effects and a peaceful overall mood. It's an excellent strain for leaning fully into comfort on the solstice, whether that means blankets, movies, or a slow night in.

Triangle Kush

Lineage: Florida-born kush with a debated history

Triangle Kush has an earthy, almost spicy aroma and a long-standing reputation among legacy consumers. Users often report introspective or creatively stimulating effects, which makes this a good match for journaling, mapping out goals, or reflecting on the past year.

Kosher Kush

Lineage: OG Kush lineage from Los Angeles

Kosher Kush is known for its robust, earthy profile and a heavy, calming effect. Users commonly associate it with deep relaxation, which pairs well with meaningful evening rituals, such as writing, gratitude practices, or simply settling into the atmosphere of the solstice.

SFV OG

Lineage: OG Kush phenotype from the San Fernando Valley

SFV OG offers pine and citrus notes along with a smoother body feel than many heavier kush varieties. Users often describe a relaxed yet focused mood, making it a solid option for reading, sketching, or working on personal projects at a leisurely pace.

Bubba Kush

Lineage: Afghan Kush phenotype crossed with Northern Lights

Bubba Kush is known for its sweet, earthy flavor and introspective calm. Users often report full body relaxation and a sense of mental quiet, which works well for long baths, slow cooking, or any ritual centered on rest.

Platinum Kush

Lineage: Believed to come from Master Kush

Platinum Kush blends earthy and floral notes with a steady soothing presence. Users often describe a relaxing experience that lends itself to reflection or light ritual work, like pulling cards or writing intentions for the year ahead.

Bottom line

The winter solstice is a natural moment to unwind and prepare for the return of light. Kush strains can support that atmosphere with grounding and calming effects that many users find helpful for reflection or rest. 

Whether your ritual is introspective, social, or simply relaxing, choosing a kush cultivar that aligns with your intention can make the longest night of the year feel a little more meaningful.

If you want to explore more strains or learn how different cultivars shape your experience, you can find additional guides in our Learn section.

Order kush strains and other cannabis products for pickup or delivery from a dispensary near you.

The post The best kush strains to prep for the longest night appeared first on Weedmaps News.

Calling All Cannabis Entrepreneurs: Apply for the NuProject Funding Growth Cohort

15 December 2025 at 15:32

NuProject, in partnership with Prosper Portland, has opened applications for the Funding Growth Cohort — a free, six-month business development program designed for founders working in Oregon’s licensed and regulated market. The cohort provides targeted support in financial systems, capital readiness, and operational strategy, helping entrepreneurs strengthen and scale in an industry where access to resources remains […]

The post Calling All Cannabis Entrepreneurs: Apply for the NuProject Funding Growth Cohort appeared first on The Weed Blog.

US Supreme Court rejects federal marijuana prohibition challenge

15 December 2025 at 14:45

The U.S. Supreme Court on Monday declined to hear a challenge to federal marijuana laws brought by four licensed cannabis companies, including a major marijuana multistate operator.

The highest court’s rejection of Canna Provisions et al v. Bondi refocuses attention on the White House and President Donald Trump’s interest in marijuana rescheduling as the $32 billion legal industry’s next great hope for major reform.

ADVERTISEMENT

Josh Schiller, a partner at law firm Boies Schiller and one of the attorneys representing the plaintiffs, did not immediately respond to a request for comment.

A spokesman for Verano Holding Corp., one of the four licensed cannabis companies that initially sued the Justice Department in October 2023, did not immediately respond to a request for comment.

Marijuana industry’s

The post US Supreme Court rejects federal marijuana prohibition challenge appeared first on GrowCola.com.

Marijuana Users ‘Pose A Greater Danger’ Than Alcohol Drinkers, Trump DOJ Tells SCOTUS In Gun Rights Case Filing

15 December 2025 at 13:13

As speculation abounds over a potential marijuana rescheduling decision by the Trump administration, the Justice Department is telling the U.S. Supreme Court that it should reverse a lower court ruling that deemed a federal ban on gun ownership by cannabis consumers to be unconstitutional—in part because people who use illegal drugs “pose a greater danger” than those who drink alcohol.

In a brief submitted to justices on Friday, U.S. Solicitor General D. John Sauer maintained the administration’s position that a federal statute restricting marijuana consumers’ gun rights, 922(g)(3), is consistent with the Constitution and does not infringe upon Second Amendment rights.

“Indeed, unlawful drug users pose a greater danger than users of alcohol, which was lawful at the founding and remained so for most of American history,” the brief says. “Congress and the Executive have determined that marijuana and other Schedule I drugs ‘ha[ve] a high potential for abuse’ and ‘a lack of accepted safety for use of the drug or other substance under medical supervision’ that justifies their criminal prohibition, unlike alcohol.”

Given Supreme Court precedent that weakened states’ rights to impose firearms restrictions that are antithetical to the founders’ intent when the Constitution was ratified, DOJ said historical

The post Marijuana Users ‘Pose A Greater Danger’ Than Alcohol Drinkers, Trump DOJ Tells SCOTUS In Gun Rights Case Filing appeared first on GrowCola.com.

YANA Wellness Becomes First Women-Owned and Operated THC Drink Line in All Virginia Total Wine Locations

15 December 2025 at 14:28

YANA Wellness, a women-owned and operated cannabis brand with a licensed dispensary in Washington, DC, officially makes history as the first hemp-derived THC beverage line in all Total Wine retail locations across Virginia. Their e-commerce platform also reaches consumers with their plant-based alternative drinks nationwide. This marks a major milestone not only for YANA as a small, women-owned business, but for all women pioneering plant-based wellness products for nationwide distribution.

The Founder and CEO of YANA, Ariana Fleishman, has made a blueprint for minority small business owners to create accessible, compliant and community-driven products. Fleishman utilizes her social media platforms to educate consumers and business owners alike.

“YANA stands for You Are Not Alone, and it is also the nickname my mom gave me as a kid. I’ve always wanted to create a community around this mission. Mental health issues are at an all-time with everything going on in the world today. I truly believe you can’t change the world until you change your own community,” Fleishman says. “Adderall and alcohol—these are so normalized in today’s society. My doctor would prescribe me Adderall for the workday to combat my ADHD. Then at night, bars and restaurants only have alcohol on the menu, which completely impairs my memory and makes me feel so sick the next day. Why is this lifestyle still so normalized? Why do we have to be so quiet when we choose to consume plants over poison?”

“Cannabis and Mushrooms are already clinically proven to be an effective medicine and provide so many life-changing benefits when purchased from lab-tested and credible sources,” she continues. “But still, the norm is to take highly addictive drugs prescribed by doctors and to drink alcohol to socialize with friends. My goal is to change this stigma by providing plant-based alternatives in mainstream settings.”

Breaking Down Prohibition Barriers and Entering the Mainstream Market

With cannabis still under federal prohibition, Fleishman purposely developed a variety of plant-based alternative blends so that at least one of their drinks on the product line would meet all jurisdictional regulations in every state. This was her strategy for expanding the brand and the plant-based alternatives culture into new markets while cannabis legalization is still uncertain nationwide.

Consumers can now find YANA drinks on restaurant menus in the DMV area and can explore the benefits of cannabinoids, functional mushrooms and adaptogens without fear of the negative stigma. YANA’s Rizzi Mushroom Elixir is a consumer favorite that contains no THC or CBD—just a federally legal blend of nootropic and adaptogenic mushrooms. Rizzi Elixir is featured at premiere social clubs in DC, like Ciel Rooftop at Marriott’s Downtown Hotel and Spark Social, DC’s first non-alcoholic social club for the LGBTQ+ community. These mainstream venues showcase how plant-based alternative drinks can be part of a holistic social wellness lifestyle—and it’s only the beginning. Virginia can now legally sell hemp-derived THC drinks in bars and restaurants with a hemp license as well. Learn more about their full product line and check out where you can buy YANA drinks near you here.

Women Leading the Future of Cannabis

YANA’s success story symbolizes the perseverance of women who have navigated the cannabis industry’s challenging transition from prohibition to legitimacy. Fleishman and her team have emerged from the “gray market” era in DC after five years in the industry to now operating a fully legal, women-run cannabis dispensary. The Chief Strategy Officer of YANA Wellness Brands, Hannah Clarke, a longtime cannabis lobbyist and consultant, emphasizes the significance of their achievements: “Women are not just participating in the industry anymore—we’re building it,” Clarke says. “This is about changing perceptions, policy and the path forward for future generations of women in cannabis.”

YANA prioritizes education, research and inclusion, integrating science, advocacy and entrepreneurship opportunities for their team of young women entering the workforce. Through wellness program collaborations with clinical psychologist Dr.Vivid and university internship programs with American University and the University of Maryland, YANA Wellness offers students the rare opportunity to study the psychological effects of cannabis and mushrooms to properly sell and promote these alternative medicines to conscious consumers.

“I’ve been interested in psychology for a while, but I never imagined I’d find an internship that focuses on the psychological effects of cannabis and mushrooms, at least not so early in my career,” said Lucrezia Brody, a YANA psychology intern and student at American University. “The research we conduct isn’t just filed away—it directly informs our patients and wellness consultants to help improve our community.”

Expanding While Stimulating the Local Economy

YANA is operated by a small team of 10 women, but their strategic partnerships with local, family-owned businesses in Virginia are how YANA is scaling effectively and stimulating the local economy. Fleishman knows that the cannabis market is already dominated by MSOs (multi-state operators) in healthcare, largely owned by publicly traded companies and pharmaceutical businesses, so she has devoted herself to working with local small businesses in all parts of the supply chain.

Pure Shenandoah is a family-owned hemp manufacturing business that provides high-quality cannabis extractions, and Brothers Craft Brewery is a family-owned brewery that YANA uses for canning their drinks. “It was very important to me to stimulate the local economy that I grew up in and keep my mission of building community through plant medicine alternatives,” Fleishman states.

YANA also just signed with Specialty Beverage, a family-owned beverage distribution company known for its large-scale deliveries to mainstream businesses. This partnership increases the accessibility of hemp-derived THC beverages to reach retail locations and restaurant menus that want to provide plant-based alternatives to alcohol.

The Evolution of YANA

In 2019, Ariana Fleishman, also known as “Ari Tokes” on social media, founded YANA Wellness as Cannabis Creatives Collectives for the DC metropolitan area to connect with others through curated social experiences. As the laws changed in DC, YANA evolved into a Holistic Wellness Center and Licensed Cannabis Dispensary.

Fleishman simultaneously spent two years developing the YANA drink line while opening the retail location so she could reach people nationwide with a variety of plant-based alternative blends. Through their social media platforms, YANA continues to advocate for responsible, inclusive and research-backed cannabis culture nationwide. Stay tuned in on their social media for updates on community events, cannabis news, and the culture here.

The post YANA Wellness Becomes First Women-Owned and Operated THC Drink Line in All Virginia Total Wine Locations appeared first on Cannabis Now.

Trump Is Trying To Boost ‘Pathetic’ Approval Ratings With Marijuana Rescheduling Move, Senator Says As Democrats Push Full Legalization

15 December 2025 at 11:12

Amid heightened rumors that the Trump administration will be moving forward on marijuana rescheduling, multiple top congressional Democrats are making the case that the reform would not go far enough—including one senator who said the move is only an attempt by the president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval ratings.

It remains to be seen whether President Donald Trump will fulfill his campaign promise to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA), which would not legalize the plant but would let marijuana businesses take federal tax deductions while removing certain research barriers. There was speculation that it’d happen late last week, and CNBC reported a decision would be made as early as Monday, while Axios said it’d occur early next year.

In the interim, Democratic lawmakers are making clear they feel that simply rescheduling cannabis would do little to address the harms of the drug war while problematically maintaining prohibition. Without Food and Drug Administration (FDA) approval, marijuana sold in dispensaries across the state would remain illicit in the eye’s of the federal government.

Sen. Ron Wyden (D-OR), who has cosponsored cannabis legalization bills, posted an

The post Trump Is Trying To Boost ‘Pathetic’ Approval Ratings With Marijuana Rescheduling Move, Senator Says As Democrats Push Full Legalization appeared first on GrowCola.com.

Marijuana Components ‘Effectively Inhibited Ovarian Cancer Cell Growth,’ Study Shows

15 December 2025 at 10:55

“Although our study is still preliminary, it lays an important foundation for future research into the potential applications of CBD and THC in ovarian cancer treatment.”

By Angharad Brewer Gillham, Frontiers

Ovarian cancer is dangerous and difficult to treat, partly because it’s hard to diagnose early, and partly because it’s often resistant to existing drugs. Now scientists looking for new treatments have identified two promising compounds in cannabis.

Both THC (delta-9-tetrahydrocannabinol) and CBD (cannabidiol) can stop ovarian cancer cells reproducing, and a combination of both compounds kills existing cancer cells. More research is needed to see if these compounds work as well outside the lab, but if these findings are confirmed they could become a source of new treatments for patients, less toxic and more effective than current options.

In the future, scientists could use drugs made from cannabis to fight ovarian cancer. A team of scientists testing the effects of two chemical compounds sourced from cannabis on ovarian cancer cells have found that both show promising anti-cancer effects. While more research will be required to turn these results into drugs which can be delivered to patients, these findings are an important opportunity to develop effective new therapies for a

The post Marijuana Components ‘Effectively Inhibited Ovarian Cancer Cell Growth,’ Study Shows appeared first on GrowCola.com.

U.S. Supreme Court Rejects Marijuana Companies’ Case Challenging Federal Prohibition

15 December 2025 at 09:41

The U.S. Supreme Court is declining to take up a case challenging the constitutionality of federal marijuana prohibition—an issue that even one of the bench’s more conservative members, Justice Clarance Thomas, had previously argued must be resolved amid the state legalization movement.

The case, Canna Provisions v. Bondi, was on the agenda for a closed-door meeting of the justices on Friday. On Monday, the court posted an order list showing that the matter failed to receive the needed votes from four justices to grant certiorari.

Massachusetts-based marijuana businesses had asked the court to take their case because they argued that federal law unconstitutionally prohibits intrastate cannabis activity, contravening the Commerce Clause.

That issue was raised in amicus briefs filed by supporters of the suit over recent weeks. That includes a public interest law firm representing a man who says federal law infringed on his property rights, libertarian think tank the Cato Institute and the Koch-founded Americans for Prosperity Foundation.

The powerhouse law firm Boies Schiller Flexner LLP submitted their petition for writ of certiorari from the court on behalf of their cannabis industry clients in October, and the Justice Department subsequently declined the opportunity to file a brief for or against the

The post U.S. Supreme Court Rejects Marijuana Companies’ Case Challenging Federal Prohibition appeared first on GrowCola.com.

Former Top State Marijuana Regulator To Testify At U.S. Senate Banking Hearing This Week

15 December 2025 at 09:07

A former top state marijuana regulator and current executive at a cannabis consulting firm will participate in a Senate committee hearing on banking issues this week.

While attention within the cannabis community is largely focused on a potentially imminent marijuana rescheduling decision by President Donald Trump, the Senate Banking Subcommittee on Financial Institutions and Consumer Protection will likely be discussing an adjacent issue for the marijuana industry: The lack of banking access for cannabis companies under federal prohibition.

Tyler Klimas—who served as executive director of the Nevada Cannabis Compliance Board (CCB) and was a founding member of the Cannabis Regulators Association (CANNRA) before becoming the founder of Leaf Street Strategies—will testify before the panel as the Democratic minority’s witness.

The hearing, which is scheduled for Tuesday, is titled “Ensuring Fair Access to Banking: Policy Levers and Legislative Solutions.” The description of the meeting doesn’t specifically mention marijuana, but Klimas’s participation signals that, at least on the Democratic side, there’s interest in addressing the industry’s banking issues.

The hearing is set to take place about two weeks after a GOP member of the House Financial Services Committee, Rep. Warren Davidson (R-OH), raised the cannabis banking issue with Comptroller Jonathan Gould at

The post Former Top State Marijuana Regulator To Testify At U.S. Senate Banking Hearing This Week appeared first on GrowCola.com.

Drug Testing Industry Group Is ‘Sounding The Alarm’ About Marijuana Rescheduling As Trump Plans Action

15 December 2025 at 07:39

A major drug testing industry organization is “sounding the alarm” amid reports that President Donald Trump may soon finalize a proposal to reschedule marijuana, arguing that the reform would “have catastrophic consequences for the safety of the United States workforce and transportation sectors.”

Ahead of a scheduled “National Conversation on the Rescheduling of Marijuana” webinar this week, National Drug & Alcohol Screening Association (NDASA) board member Emilee Avery said in a press release that rescheduling “will dismantle critical safety measures that have protected our roads, airways, and communities for decades.”

“The guardrails implemented under President Reagan’s administration 30 years ago have been instrumental in ensuring that safety-sensitive positions, such as truck drivers, school bus drivers, and airline pilots, remain drug-free,” she said. “This decision threatens to undo all of that progress.”

A final decision hasn’t been made at this point, but multiple sources have claimed that there’s an executive order that could be issued imminently, possibly directing the attorney general to complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA).

Cannabis industry stakeholders are holding out hope that the reform will be achieved as soon as possible, but opponents—including NDASA and

The post Drug Testing Industry Group Is ‘Sounding The Alarm’ About Marijuana Rescheduling As Trump Plans Action appeared first on GrowCola.com.

HpLVd: The most feared viroid in cannabis cultivation and how to protect your clones

15 December 2025 at 03:00

Imagine this: you’ve spent months nurturing a batch of premium cannabis clones, hand-selected from a trusted source. They’re vigorous, vibrant, and primed for a bumper harvest. But when flowering kicks in, disaster strikes: the plants stall out, the buds turn into small, sad, airy little balls, and your yields crash by up to 50%. Welcome to the world of Hop Latent Viroid (HpLVd), the invisible destroyer that has become the cannabis grower’s worst nightmare. Often dubbed the “COVID of cannabis”, HpLVd doesn’t just hit hard; it spreads silently through your clones, underscoring why plant health is non-negotiable for any grower.

In this guide, we’ll demystify plant viruses (and viroids like HpLVd) in plain English—think science served with a touch of grow-room wisdom. We’ll trace the stealthy history of HpLVd, highlight its red flags, and arm you with battle-tested strategies to prevent and fight it. Whether you’re a seasoned grower or just dipping your toes into cloning, this is your roadmap to resilient, virus-free crops. Let’s dive in.

Hop Latent Viroid - HpLVd

Hop Latent Viroid – HpLVd

Plant viruses 101: Nature’s saboteurs

Before we zoom in on HpLVd, let’s pull back and look at the bigger picture: plant viruses and viroids. These tiny lurkers are the ultimate uninvited guests in your garden, but understanding them is your first line of defence.

Cannabis viruses

At their core, plant viruses are fragments of genetic code—either RNA or DNA—wrapped in a protein coat (or not, in the case of viroids). They’re not alive the way bacteria are; they’re more like rogue software that needs a host computer (your plant’s cells) to run. Once inside, they hijack the cell’s machinery: the plant’s own ribosomes and enzymes are pressed into service to crank out viral copies instead of essential plant proteins. This replication frenzy drains resources, disrupts metabolism, and triggers weird growth patterns.

Think of it like this: a virus sneaks into your plant’s “factory” (the cell nucleus or cytoplasm) through a back door—a pruning wound, an insect bite, or even contaminated tools. It tricks the factory workers (enzymes) into building a viral assembly line, flooding the system until cells burst or start sending distress signals to their neighbours. The result? A cascade of chaos.

Viroids, the category HpLVd belongs to, are even more stripped-down villains: naked loops of RNA with no protein coat, only 250–400 nucleotides long. They’re the minimalist hackers—small enough to slip past defences and replicate using the plant’s nuclear machinery via a “rolling-circle” method, spitting out error-prone copies that evolve on the fly.

Transmission is their superpower. Unlike animal viruses that travel by air or touch, plant viruses rely on vectors:

  • Mechanical spread: sap from infected plants on your scissors or hands gets transferred to healthy ones during cloning or trimming.
  • Insect messengers: aphids, whiteflies, or leafhoppers sip virus-laden sap and deposit it elsewhere.
  • Vegetative betrayal: grafts, cuttings, or clones carry the load directly from the mother plant to the babies.
  • Seed surprises: rare, but some viruses travel in pollen or embryos.

Symptoms vary by virus and host, but often include:

  • Mosaic patterns: mottled, yellow-green leaves that look like a bad paint job.
  • Stunting: dwarfed growth, as if the plant hit a permanent growth plateau.
  • Necrosis: dead spots or wilting, the plant’s SOS flare.
  • Yield impacts: fewer flowers, smaller fruits, or watered-down potency—devastating for cannabis.

The catch? Many infections lurk asymptomatically, only showing up under stress like heat, drought, or flowering. For growers, that means vigilance: healthy plants fight back better, so balanced nutrition, optimal light, and low-stress environments are your baseline armour. Now, let’s meet the viroid that’s driving the cannabis world crazy.

HpLVd: From hop fields to cannabis chaos—a brief history

Hop Latent Viroid earned its name from humble beginnings in hop yards. Discovered in 1987 in Spain, it first appeared as an innocuous RNA oddity in Humulus lupulus (hop, the cannabis plant’s botanical cousin in the Cannabaceae family). By 1988, surveys in Germany revealed it was infecting 90–100% of European hop cultivars—yet hops largely shrugged it off with mild symptoms, like a modest drop in cone yields (8–37%) or bitter acids (15–50%). Brewers noticed subtler beer flavours from altered terpenes, but there was no industry-wide panic.

Fast-forward to the cannabis boom. HpLVd jumped species around 2017, probably via shared propagation tools or infected germplasm in U.S. facilities. The first rumblings showed up on online forums in 2014, with growers complaining about the “dudding disease”—stunted, brittle plants producing airy buds. By 2019, high-throughput sequencing nailed it: HpLVd was the culprit in California, where a survey by Dark Heart Nursery estimated 90% of operations were contaminated. It then tore through North America, Canada, and beyond, with infection rates averaging 30% across the industry and economic hits nearing $4 billion annually in lost yields and potency.

Why cannabis? Unlike resilient hops, weed is a softer target. HpLVd’s 256-nucleotide circular RNA thrives in cannabis cells, replicating in the nucleolus and clogging up metabolite production. It hits glandular trichomes especially hard, slashing THC by 50–70%, terpenes by up to 40%, and overall vigour. Two variants (Can1 and Can2) have adapted, with mutations like U225A boosting infectivity. It’s pleiotropic—symptoms range from none to full-blown nightmare—making it a shapeshifter in your grow.

Bottom line, HpLVd’s “latent” label is a lie in cannabis: it hides in veg, then explodes in flower, turning premium clones into liabilities.

Spotting the cannabis virus: HpLVd symptoms in your grow

Electron microscope image of cannabis trichomes

Electron microscope image of cannabis trichomes. The trichomes on the left are stunted and smaller due to infection with Hop Latent Viroid. Right: healthy trichomes. Image source: Simon Fraser University, Canada

Early detection is your crop’s guardian angel, but HpLVd plays hide-and-seek like a pro. In clones from infected mothers, it often lies dormant until week 4+ of flower, when stress unmasks it. Here’s what to watch for, especially if you run a clone-heavy setup:

  • Stunting and structural changes: shorter internodes, more horizontal sprawl than vertical reach, and overall dwarfing—as if the plant were stuck in permanent juvenile mode.
  • Brittle stems and leaves: they snap like dry twigs; foliage yellows (chlorosis) or curls unevenly.
  • Dudding disaster: the hallmark—buds stay small, loose, and sparse. Trichomes ripen early (amber too soon), resin production tanks, and aromas fade.
  • Potency crash: lab tests show cannabinoid drops (THC down 50%+), terpene loss (myrcene oddly elevated, β-caryophyllene down 13–29%), and weaker flavour.

Not all cultivars respond the same way; some coast with few symptoms while others fail en masse. Co-infections (e.g., with other viroids) amplify the damage. Pro tip: scout weekly under magnification—uneven trichome distribution is a screaming red flag. When in doubt, test: RT-PCR on leaf samples from both old and new growth is the gold standard, catching around 30% of silent carriers.

Transmission traps: Why clones are HpLVd’s highway

HpLVd doesn’t fly or float; it’s a full-contact sport. As a viroid, it needs direct sap-to-sap transfer—perfect for clone-heavy operations.

  • Clone-borne contagion: the big one. Infected mother plants pass it 100% to cuttings. One sketchy clone in your tray? Boom—your whole batch is toast.
  • Tool terrorism: pruners, scalpels, or gloves smeared with sap spread it like wildfire. Recirculating hydro systems or shared reservoirs amplify the problem.
  • Human highways: workers touching multiple plants without washing? Instant vector.
  • Rare routes: pollen/seed transmission is negligible; no known insect vectors.

In cannabis, where 70%+ of crops start from clones, this transmission chain explains the explosion. A single imported cutting can doom an entire facility. Lesson: plant health starts upstream—vet your sources ruthlessly.

How to prevent it: Protect your clones from day one

Good news: HpLVd is beatable with prevention. Focus on clean inputs and rock-solid hygiene—your clones will thank you.

  1. Source smart: ditch untested clones; opt for certified clean stock or start from seed (much lower risk). Quarantine new arrivals for 30 days, testing in week 3 via lab RT-PCR or dot-blot.
  2. Sanitise like a surgeon: bleach (5–10% sodium hypochlorite) or Virkon S (2%) on tools—alcohol doesn’t cut it, since it precipitates RNA. Heat-treat blades at 160°C for 10 minutes. Swap PPE between plants; wash hands obsessively.
  3. Segment your grow: keep veg and flower separated; use dedicated cloners per batch. Filter water and avoid runoff mixing.
  4. Boost resilience: healthy plants fight back via RNA silencing. Dial in balanced nutrients at the right pH, stable temps, and low stress—strong clones slow viral buildup.
  5. Test religiously: sample 10–20% of your stock every quarter. Early wins save whole harvests.

These steps cut risk by about 90%—proven in hop yards and cannabis labs alike.

Fighting an outbreak: Damage control when HpLVd hits

Found an infection? Don’t panic—move fast. There’s no silver-bullet antiviral, but here’s your playbook:

  • Cull ruthlessly: chop symptomatic plants immediately; burn or bleach waste to kill persistent RNA.
  • Rescue team: for salvageable mothers, try meristem-tip culture (micro-propagating tiny <0.5 mm shoot tips) paired with cold (2–4°C for months) or heat therapy (36°C for 2 weeks). This can knock down viral load via mutations but it’s not foolproof—re-infection is a constant threat.
  • Facility wash-down: deep-clean everything; use urea or chloropicrin for soil. Restart with verified clean material.
  • Long-term R&D: breed resistant cultivars or deploy RNA interference—emerging tools, but not quite ready for your grow room yet.

Recovery hurts yields in the short term, but rebuilds trust in your system. Remember: one clean cycle resets the clock.

Final harvest: Put plant health first for thriving grows

Comparison between a healthy plant (right) and a plant affected by HLVd (left), where the viroid’s influence on trichome production is clearly visible. Source: Dark Heart Nursery

HpLVd isn’t just a viroid—it’s a wake-up call. In an industry hooked on clones for speed and uniformity, its spread drives home why plant health trumps everything. From virus basics to outbreak ops, once you’re armed with the right knowledge, you can grow with confidence, dodge duds, and deliver your best.

At Alchimiaweb, we aim to empower growers by giving them the tools to succeed. Stock up on sterile gear, test kits, or clean genetics today—your next round of clones is waiting. Got HpLVd stories or tips to share? Drop them in the comments. Grow Happiness!

Bibliography

    1. Adkar-Purushothama, C. R., Sano, T., & Perreault, J. P. (2023). Hop latent viroid: A hidden threat to the cannabis industry. Viruses, 15(3), 681. https://doi.org/10.3390/v15030681
    2. Punja, Z. K., Collyer, D., Scott, C., Holmes, J., Zhao, Y. Y., Hinz, F., … & Reed, S. (2023). Symptomology, prevalence, and impact of hop latent viroid on greenhouse-grown cannabis (Cannabis sativa L.) plants in Canada. Canadian Journal of Plant Pathology, 46(2), 174–197. https://doi.org/10.1080/07060661.2023.2279184
    3. Punja, Z. K., Scott, C., Tso, H. H., Munz, J., & Buirs, L. (2025). Transmission, spread, longevity and management of hop latent viroid, a widespread and destructive pathogen affecting cannabis (Cannabis sativa L.) plants in North America. Plants, 14(5), 830. https://doi.org/10.3390/plants14050830
    4. Puchta, H., Ramm, K., & Sänger, H. L. (1988). The molecular structure of 26 S rRNA from Humulus lupulus L. (hops) and the sequence of a viroid-like RNA associated with hop stunt disease. Nucleic Acids Research, 16(9), 4197–4216. https://doi.org/10.1093/nar/16.9.4197
    5. Warren, J. G., Mercado, J., & Grace, D. (2019). Occurrence of hop latent viroid causing disease in Cannabis sativa in California. Plant Disease, 103(10), 2699. https://doi.org/10.1094/PDIS-03-19-0530-PDN
    6. Viruses and Viroids – an overview. (n.d.). In ScienceDirect Topics. Elsevier. Retrieved November 24, 2025, from https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/viruses-and-viroids
    7. Hop latent viroid in hemp. (n.d.). OSU Extension Service. Oregon State University. Retrieved November 24, 2025, from https://extension.oregonstate.edu/catalog/em-9570-hop-latent-viroid-hemp
    8. Kovalchuk, I., Pellino, M., Rigault, P., van Velzen, R., Bhalerao, R., Clark, J., … & Kovalchuk, A. (2020). The Genomics of Cannabis and Its Conservation. Genome Biology and Evolution, 12(3), 292–312. (For general viroid context; referenced in broader reviews)
    9. Hop Latent Viroid: A Guide to Sampling, Testing and Lab Selection. (2024, July 9). Cannabis Business Times. Retrieved November 24, 2025, from https://www.cannabisbusinesstimes.com/disease/cannabis-plant-disease/news/15686586/hop-latent-viroid-a-guide-to-sampling-testing-and-lab-selection
    10. Bektaş, M., Sõmera, M., Faggioli, F., & Pallas, V. (2019). First report of hop latent viroid on marijuana (Cannabis sativa) in California. Plant Disease, 103(10), 2699. https://doi.org/10.1094/PDIS-03-19-0530-PDN

The post HpLVd: The most feared viroid in cannabis cultivation and how to protect your clones appeared first on Alchimia blog.

❌
❌